| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/13/2002 | EP1255858A2 Improved mutation analysis of the nf1 gene |
| 11/13/2002 | EP1255857A2 Method of identifying toxic agents using differential gene expression |
| 11/13/2002 | EP1255856A2 Digital amplification |
| 11/13/2002 | EP1255855A2 Diagnosis of primary congenital glaucoma |
| 11/13/2002 | EP1255853A2 Methods of protein destabilization and uses thereof |
| 11/13/2002 | EP1255850A1 AMPLIFICATION OF $i(CYP24) AND USES THEREOF |
| 11/13/2002 | EP1255849A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 11/13/2002 | EP1255848A2 Methods for enhancing the production of cytokines in cell cultur e |
| 11/13/2002 | EP1255847A2 Alteration of growth and adaptation under hypoxic conditions |
| 11/13/2002 | EP1255846A2 Multi-gene expression constructs containing modified inteins |
| 11/13/2002 | EP1255845A2 Modified cytokines for use in cancer therapy |
| 11/13/2002 | EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 11/13/2002 | EP1255843A1 Human proteases and polynucleotides encoding the same |
| 11/13/2002 | EP1255842A1 Larynx carcinoma-associated protein larcap-1 |
| 11/13/2002 | EP1255841A2 Use of palatinase and trehalulase sequences as nutritive markers in transformed cells |
| 11/13/2002 | EP1255840A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 11/13/2002 | EP1255839A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 11/13/2002 | EP1255838A1 Dehiscence gene and methods for regulating dehiscence |
| 11/13/2002 | EP1255837A2 Il-17 like molecules and uses thereof |
| 11/13/2002 | EP1255836A2 Novel, central nervous protein, that modulates k?+ flows |
| 11/13/2002 | EP1255835A2 Polypeptides and nucleic acids encoding same |
| 11/13/2002 | EP1255834A2 Gtpase activating proteins |
| 11/13/2002 | EP1255833A2 Polypeptides and nucleic acids encoding same |
| 11/13/2002 | EP1255832A1 18057 protein, a seven transmembrane protein |
| 11/13/2002 | EP1255831A2 Sperm specific proteins |
| 11/13/2002 | EP1255830A2 Cbp86, a sperm specific protein |
| 11/13/2002 | EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 11/13/2002 | EP1255828A2 Small oligonucleotides with anti-tumor activity |
| 11/13/2002 | EP1255827A2 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents |
| 11/13/2002 | EP1255826A2 Protein design automation for protein libraries |
| 11/13/2002 | EP1255825A2 Male tissue-specific regulatory region and method of using same |
| 11/13/2002 | EP1255824A2 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 11/13/2002 | EP1255822A2 Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure |
| 11/13/2002 | EP1255821A2 Protein c derivatives |
| 11/13/2002 | EP1255820A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof |
| 11/13/2002 | EP1255819A2 Human kinases |
| 11/13/2002 | EP1255818A2 Methods for using 20893, a human protein kinase |
| 11/13/2002 | EP1255817A1 Nucleic acids, proteins, and antibodies |
| 11/13/2002 | EP1255815A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 11/13/2002 | EP1255814A1 7tm receptor axor36 |
| 11/13/2002 | EP1255813A1 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 11/13/2002 | EP1255780A1 Methods and compositions for generating human monoclonal antibodies |
| 11/13/2002 | EP1255778A2 Nucleic acids, proteins, and antibodies |
| 11/13/2002 | EP1255777A1 Nucleic acids, proteins, and antibodies |
| 11/13/2002 | EP1255776A1 Nucleic acids, proteins, and antibodies |
| 11/13/2002 | EP1255774A1 Transgenic animal model for obesity expressing foxc2 |
| 11/13/2002 | EP1255773A2 Insecticidal proteins from bacillus thuringiensis |
| 11/13/2002 | EP1255771A1 Novel compounds |
| 11/13/2002 | EP1255769A2 Universal procedure for refolding recombinant proteins |
| 11/13/2002 | EP1255768A2 Nucleic acids, proteins, and antibodies |
| 11/13/2002 | EP1255767A2 Nucleic acids, proteins, and antibodies |
| 11/13/2002 | EP1255766A2 Nucleic acids, proteins, and antibodies |
| 11/13/2002 | EP1255716A1 Segment synthesis |
| 11/13/2002 | EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 11/13/2002 | EP1255447A2 Biopolymer thickener |
| 11/13/2002 | EP1255437A1 Transgenic animal expressing a multiple mutated form of presenilin 1 |
| 11/13/2002 | EP1060261A4 Poly zinc finger proteins with improved linkers |
| 11/13/2002 | EP1012162B1 Soluble proteins |
| 11/13/2002 | EP1003887B1 Use of a virus dna as promoter |
| 11/13/2002 | EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 11/13/2002 | EP0814777B1 Stable lipid-comprising drug delivery complexes and methods for their production |
| 11/13/2002 | EP0778898B1 Reduction of nonspecific hybridization by using novel base-pairing schemes |
| 11/13/2002 | EP0738281B1 Peptides and their uses against psoriasis |
| 11/13/2002 | EP0722503B1 Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria |
| 11/13/2002 | EP0705271B1 Hybridization and sequencing of nucleic acids |
| 11/13/2002 | EP0697889B1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |
| 11/13/2002 | EP0693940B1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells |
| 11/13/2002 | EP0606452B1 Vector vaccines of recombinant feline herpesvirus |
| 11/13/2002 | EP0584284B9 Recombinant dna-derived cholera toxin subunit analogs |
| 11/13/2002 | EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine |
| 11/13/2002 | CN1379823A Method for production of L-cysteine or L-cysteine derivatives by fermentation |
| 11/13/2002 | CN1379822A D-gluconolactone oxidase gene and method for producing recombinant D-gluconolactone oxidase |
| 11/13/2002 | CN1379821A Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 11/13/2002 | CN1379820A Lentiviral vectors for preparation of immunotherapeutical compositions |
| 11/13/2002 | CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof |
| 11/13/2002 | CN1379818A Process for biological production of 1,3-propanediol with high titer |
| 11/13/2002 | CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1 |
| 11/13/2002 | CN1379816A Human G-protein coupled receptor |
| 11/13/2002 | CN1379815A BAFF receptor (BCMA), immunoregulatory agent |
| 11/13/2002 | CN1379814A Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 11/13/2002 | CN1379813A Method to improve stability and broaden PH range of family G/11 xylanases |
| 11/13/2002 | CN1379812A Process for producing microorganism-origin transglutaminase |
| 11/13/2002 | CN1379810A Substrates for nucleic acid immobilization onto solid supports |
| 11/13/2002 | CN1379783A Methods for increasing plant cell proliferation by functionally inhibiting plant cyclin inhibitor gene |
| 11/13/2002 | CN1379782A Subunit optimized fusion proteins |
| 11/13/2002 | CN1379683A 疫苗 Vaccine |
| 11/13/2002 | CN1379676A Blood plasma replacement composition |
| 11/13/2002 | CN1379112A Process for preparing peptide antibiotics with efficient expression |
| 11/13/2002 | CN1379109A Adenovirus carrier for specifically killing primary liver cancer cells and its application |
| 11/13/2002 | CN1379108A Refractory phosphoheptose isomerase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379107A Refractory cysteine synthase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379106A Refractory cytosine deaminase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379105A Refractory Se-base phosphatide esterase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379104A Refractory mucleotide biphosphate kinase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379103A Refractory glucosan phosphorylase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379102A Refractory S-adenosylmethionine synthetase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379101A Refractory thymidine phosphorylase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379100A Refractory dihydroorate synthase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379099A Refractory 6-phosphogluconate dehydrogenase gene and its polypeptide coded by it and preparing process |
| 11/13/2002 | CN1379098A Refractory histidinol dehydrogenase gene and its polypeptide coded by it and preparing process |